Last reviewed · How we verify
Acute coronary syndrome
Approved treatments
- Isoptin
- Lopressor · Generic (originally Ciba-Geigy/Novartis)
Cardioselective beta-1 adrenergic receptor blocker that reduces heart rate, blood pressure, and myocardial oxygen demand. - Brilinta · AstraZeneca
- Aggrastat · Medicure
Aggrastat works by blocking the integrin alpha-IIb/beta-3 receptor on platelets, preventing them from aggregating and forming blood clots. - Brilinta · AstraZeneca
- Integrilin · Merck & Co.
Integrilin blocks the binding of fibrinogen to platelets, preventing them from clumping together and forming clots. - Effient · Cosette
Effient works by blocking the P2Y12 receptor on platelets, preventing them from aggregating and forming blood clots. - Plavix · Generic (originally Sanofi/BMS)
Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis. - integrilin · University of Cincinnati
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acute coronary syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Acute coronary syndrome treatment landscape brief
- Acute coronary syndrome treatment updates RSS
Frequently asked questions about Acute coronary syndrome
What drugs treat Acute coronary syndrome?
Tracked treatments include Isoptin, Lopressor, Brilinta, Aggrastat, Integrilin, Effient, Plavix, integrilin.
What is the treatment for Acute coronary syndrome?
Standard treatment for Acute coronary syndrome includes Isoptin, Lopressor, Brilinta, Aggrastat, Integrilin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Acute coronary syndrome patent cliff · Acute coronary syndrome CI report
- Treatment: Isoptin
- Treatment: Lopressor · Generic (originally Ciba-Geigy/Novartis)
- Treatment: Brilinta · AstraZeneca
- Treatment: Aggrastat · Medicure
- Treatment: Brilinta · AstraZeneca
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing